I.G. Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$21.2M Sell
238,583
-9,319
-4% -$709K 0.11% 108
2017
Q2
$18M Hold
247,902
0.09% 124
2017
Q1
$16.2M Sell
247,902
-120,027
-33% -$7.55M 0.08% 133
2016
Q4
$23M Sell
367,929
-293,840
-44% -$17.9M 0.12% 104
2016
Q3
$41.7M Sell
661,769
-7,793
-1% -$504K 0.16% 100
2016
Q2
$41.5M Buy
669,562
+68,796
+11% +$4.19M 0.16% 99
2016
Q1
$34.3M Sell
600,766
-161,301
-21% -$8.99M 0.14% 97
2015
Q4
$45.1M Sell
762,067
-520,150
-41% -$30M 0.19% 83
2015
Q3
$69.8M Sell
1,282,217
-284,797
-18% -$18.5M 0.29% 65
2015
Q2
$105M Sell
1,567,014
-483,088
-24% -$31.5M 0.4% 58
2015
Q1
$120M Buy
2,050,102
+1,232,083
+151% +$74.4M 0.46% 47
2014
Q4
$53.5M Buy
818,019
+97,661
+14% +$6.16M 0.19% 77
2014
Q3
$41.6M Buy
720,358
+284,980
+65% +$15.8M 0.15% 98
2014
Q2
$24.6M Buy
435,378
+45,619
+12% +$2.39M 0.08% 141
2014
Q1
$20M Buy
389,759
+82,911
+27% +$4.19M 0.07% 158
2013
Q4
$16.2M Buy
306,848
+33,942
+12% +$1.67M 0.06% 178
2013
Q3
$12.2M Buy
272,906
+134,171
+97% +$5.95M 0.05% 201
2013
Q2
$5.74M Buy
+138,735
New +$6.07M 0.02% 306

Other funds holding ABBV

I.G. Investment Management's ABBV Position: Q3 2017 in Review

I.G. Investment Management reduced its AbbVie (ABBV) stake by 3.8% in Q3 2017, selling an estimated $709K and leaving 238,583 shares worth $21.2M. The position accounts for 0.11% of the portfolio, ranked #108.

I.G. Investment Management first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. The position peaked at $120M in Q1 2015. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • I.G. Investment Management held 238,583 shares of AbbVie worth $21.2M as of Q3 2017.
  • I.G. Investment Management sold 9,319 AbbVie shares in Q3 2017, an estimated $709K.
  • AbbVie made up 0.11% of I.G. Investment Management's portfolio in Q3 2017, its #108 holding.
  • I.G. Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
  • I.G. Investment Management's AbbVie position peaked at $120M in Q1 2015.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.